BioPlus Acquisition Corp Unit

Shell Companies
Financial Services

Prices are adjusted according to historical splits.

BioPlus Acquisition Corp Unit Stock Price


Today's Low:
Today's High:
Open Price:
52W Low:
52W High:
Prev. Close:

Company Statistics

Market Cap.:
Book Value:
Revenue TTM:
Operating Margin TTM:
Gross Profit TTM:
Profit Margin:
Return on Assets TTM:
Return on Equity TTM:

Company Profile

BioPlus Acquisition Corp Unit had its IPO on 2021-12-03 under the ticker symbol BIOSU.

The company operates in the Financial Services sector and Shell Companies industry. BioPlus Acquisition Corp Unit has a staff strength of 0 employees.

Stock update

Shares of BioPlus Acquisition Corp Unit opened at $10.46 at the start of the last trading session i.e. 2023-03-24.

The stocks traded within a range of $10.46 - $10.46, and closed at $10.46.

This is a +0.1% increase from the previous day's closing price.

A total volume of 100 shares were traded at the close of the day’s session.

In the last one week, shares of BioPlus Acquisition Corp Unit have increased by +0.19%.

BioPlus Acquisition Corp Unit's Key Ratios

BioPlus Acquisition Corp Unit has a market cap of $0, indicating a price to book ratio of 0 and a price to sales ratio of 0.

In the last 12-months BioPlus Acquisition Corp Unit’s revenue was $0 with a gross profit of $0 and an EBITDA of $0. The EBITDA ratio measures BioPlus Acquisition Corp Unit's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, BioPlus Acquisition Corp Unit’s operating margin was 0% while its return on assets stood at 0% with a return of equity of 0%.

In Q3, BioPlus Acquisition Corp Unit’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.

BioPlus Acquisition Corp Unit’s PE and PEG Ratio

Forward PE
Trailing PE

Its diluted EPS in the last 12-months stands at $0 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into BioPlus Acquisition Corp Unit’s profitability.

BioPlus Acquisition Corp Unit stock is trading at a EV to sales ratio of 0 and a EV to EBITDA ratio of 0. Its price to sales ratio in the trailing 12-months stood at 0.

BioPlus Acquisition Corp Unit stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets
$236.51 million
Total Liabilities
Operating Cash Flow
Capital Expenditure
Dividend Payout Ratio

BioPlus Acquisition Corp Unit ended 2023 with $236.51 million in total assets and $0 in total liabilities. Its intangible assets were valued at $236.51 million while shareholder equity stood at $221.42 million.

BioPlus Acquisition Corp Unit ended 2023 with $0 in deferred long-term liabilities, $288453.00 in other current liabilities, in common stock, $-14460528.00 in retained earnings and $0 in goodwill. Its cash balance stood at $107073.00 and cash and short-term investments were $0. The company’s total short-term debt was $0 while long-term debt stood at $5.00 million.

BioPlus Acquisition Corp Unit’s total current assets stands at $628556.00 while long-term investments were $0 and short-term investments were $0. Its net receivables were $0 compared to accounts payable of $0 and inventory worth $0.

In 2023, BioPlus Acquisition Corp Unit's operating cash flow was $0 while its capital expenditure stood at $0.

Comparatively, BioPlus Acquisition Corp Unit paid $0 in dividends in 2023.

Other key metrics

Current Trading Price
52-Week High
52-Week Low
Analyst Target Price

BioPlus Acquisition Corp Unit stock is currently trading at $10.46 per share. It touched a 52-week high of $10.46 and a 52-week low of $10.46. Analysts tracking the stock have a 12-month average target price of $.

Its 50-day moving average was $10.38 and 200-day moving average was $10.16 The short ratio stood at 0.08 indicating a short percent outstanding of 0%.

Around 161.3% of the company’s stock are held by insiders while 464% are held by institutions.

Frequently Asked Questions About BioPlus Acquisition Corp Unit

The stock symbol (also called stock or share ticker) of BioPlus Acquisition Corp Unit is BIOSU

The IPO of BioPlus Acquisition Corp Unit took place on 2021-12-03

Similar Industry Stocks (Shell Companies)

Last Price

Most Active

Last Price

Top Gainers

Last Price

Top Losers

Last Price
Imara Inc (IMRA)


BioPlus Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses in the life sciences industry. The company was incorporated in 2021 and is based in New York, New York.


260 Madison Avenue, New York, NY, United States, 10026